Elena Camporesi

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Distinct mechanistic pathways of early tauopathy revealed by MAPT mutations.

Distinct mechanistic pathways of early tauopathy revealed by MAPT mutations.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders.

Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders.

Journal: Nature communications

Published: October 22, 2025

Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study.

Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study.

Journal: Acta neuropathologica

Published: May 07, 2025

Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome.

Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 23, 2024

Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.

Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.

Journal: Journal of neurochemistry

Published: December 22, 2024

Age- and amyloid-β-dependent initiation of neurofibrillary tau tangles: an improved mouse model of Alzheimer's disease without mutations in MAPT.

Age- and amyloid-β-dependent initiation of neurofibrillary tau tangles: an improved mouse model of Alzheimer's disease without mutations in MAPT.

Journal: bioRxiv : the preprint server for biology

Published: November 22, 2024

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.

Journal: Acta neuropathologica

Published: February 02, 2024

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Journal: medRxiv : the preprint server for health sciences

Published: January 03, 2024

Tau protein profiling in tauopathies: a human brain study.

Tau protein profiling in tauopathies: a human brain study.

Journal: Molecular neurodegeneration

Published: December 20, 2023

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Journal: Nature communications

Published: July 17, 2023

In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds.

In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds.

Journal: Nature neuroscience

Published: May 28, 2023

Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations.

Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations.

Journal: Acta neuropathologica communications

Published: February 14, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026